These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 1017580)

  • 1. Predication of the effect of carcinostatic agents on tumor-bearing host by the sensitivity test using acid phosphatase activity in vitro.
    Kondo T; Ichihashi H; Imaizumi M
    Gan; 1976 Oct; 67(5):633-9. PubMed ID: 1017580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Study on the sensitivity test of carcinostatic agents by acid phosphatase activity.
    Imaizumi M
    Nagoya J Med Sci; 1972 Mar; 34(4):315-33. PubMed ID: 4665966
    [No Abstract]   [Full Text] [Related]  

  • 3. In vitro test for sensitivity of tumor to carcinostatic agents.
    Kondo T; Imamura T; Ichihashi H
    Gan; 1966 Apr; 57(2):113-21. PubMed ID: 4289605
    [No Abstract]   [Full Text] [Related]  

  • 4. [Studies on the prevention of side-effects of the anti-cancer agent, mitomycin C by xylitol].
    Iwasa H; Takahashi M
    Gan No Rinsho; 1968 Jul; 14(7):561-5. PubMed ID: 5749780
    [No Abstract]   [Full Text] [Related]  

  • 5. The role of lysosomes in cancer chemotherapy. 3. Influence of plasmin on the lysosomes of tumor cells and on the cytocidal effect of mitomycin-C.
    Shimoyama M; Niitani H; Taniguchi T; Inagaki J; Kimura K
    Gan; 1969 Feb; 60(1):33-9. PubMed ID: 4238525
    [No Abstract]   [Full Text] [Related]  

  • 6. Host resistance against tumor and its synergic effect with cancer chemotherapy.
    Sato R
    Gan; 1967 Jun; 58(3):211-20. PubMed ID: 6081225
    [No Abstract]   [Full Text] [Related]  

  • 7. Carcinostatic effect of aliphatic aldehydes and aldehyde dehydrogenase activity in Ehrlich carcinoma, Sarcoma 180, and Yoshida AH 130 hepatoma.
    Perin A; Sessa A; Ciaranfi E
    Cancer Res; 1978 Jul; 38(7):2180-4. PubMed ID: 207425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on anti-tumor activity of soedomycin, a new anti-tumor agent. II. Anti-tumor effect on Ehrlich ascites tumor and Yoshida sarcoma, and an outline of clinical application to human patients with carcinoma.
    Soeda M
    Nihon Igaku Hoshasen Gakkai Zasshi; 1967 Feb; 26(11):1492-501. PubMed ID: 5231928
    [No Abstract]   [Full Text] [Related]  

  • 9. [Factors affecting the effect of anticancer drugs. 1. The effect of mitomycin C in vitro and in vivo].
    Ishikawa Y; Fukushima M; Horimai T; Sato T; Machida S
    Igaku To Seibutsugaku; 1967 Feb; 74(2):96-100. PubMed ID: 5624336
    [No Abstract]   [Full Text] [Related]  

  • 10. Antitumor activity of a novel antitumor antibiotic, quinocarmycin citrate (KW2152).
    Fujimoto K; Oka T; Morimoto M
    Cancer Res; 1987 Mar; 47(6):1516-22. PubMed ID: 2434218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proliferation kinetics of tumor and host cells after chemotherapeutic treatment.
    Takemitsu A
    Nagoya J Med Sci; 1975 Mar; 37(3-4):59-70. PubMed ID: 1160987
    [No Abstract]   [Full Text] [Related]  

  • 12. A mitomycin C-resistant Jensen rat sarcoma: chemotherapy studies.
    Sugiura K; Merker PC
    Cancer Res; 1963 Sep; 23(8 Pt 2):1475-82. PubMed ID: 5878213
    [No Abstract]   [Full Text] [Related]  

  • 13. The role of lysosomes in cancer chemotherapy. II. Effect of mitomycin-C injection on lysosomal enzymic activities of Yoshida ascites sarcoma cells.
    Niitani H; Suzuki A; Shimoyama M; Kimura K
    Gan; 1966 Apr; 57(2):193-200. PubMed ID: 5959699
    [No Abstract]   [Full Text] [Related]  

  • 14. Antitumor activity of 7-N-[[2-[[2-(gamma-L-glutamylamino)ethyl]dithio]ethyl]]-mitomycin C.
    Morimoto M; Ashizawa T; Ohno H; Azuma M; Kobayashi E; Okabe M; Gomi K; Kono M; Saitoh Y; Kanda Y
    Cancer Res; 1991 Jan; 51(1):110-5. PubMed ID: 1988076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antitumor activity of 7-n-(p-hydroxyphenyl)-mitomycin C in experimental tumor systems.
    Imai R; Morimoto M; Marumo H; Kobayashi T; Tsuruo T; Inaba M; Tsukagoshi S; Sakurai Y
    Gan; 1981 Dec; 72(6):944-9. PubMed ID: 6804296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta-glucuronidase activity of Yoshida ascites hepatomas of different drug-sensitivity and its change after treatment of host rats with various anticancer agents.
    Abe I; Sato S
    Gan; 1976 Feb; 67(1):55-65. PubMed ID: 57896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Ineffectiveness of a drug combination on Yoshida sarcoma and Walker carcinosarcoma 256 of the rat and on Ehrlich carcinoma of the mouse].
    Zeller WJ; Wiessler M; Adzersen KH
    Arzneimittelforschung; 1972 Mar; 22(3):575-7. PubMed ID: 5067931
    [No Abstract]   [Full Text] [Related]  

  • 18. [Experimental and clinical studies on cancer chemotherapy--enhancement of the cytocidal effect of Mitomycin-C by one of lysosome labilizer, plasmin].
    Taniguchi T
    Nihon Gan Chiryo Gakkai Shi; 1972 Dec; 7(4):290-309. PubMed ID: 4266268
    [No Abstract]   [Full Text] [Related]  

  • 19. Affinity of intraperitoneally injected activated carbon particles adsorbing mitomycin C to tumor surface of Yoshida sarcoma.
    Hagiwara A; Takahashi T; Iwamoto A; Yoneyama C; Itoh M; Sasabe T
    Anticancer Drug Des; 1990 Nov; 5(4):359-69. PubMed ID: 2127181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Acid and alkaline phosphatase activity in the cells of ascites tumors. Effect of radiations].
    Illeni MT; Pagani G; Raimondi L
    Boll Soc Ital Biol Sper; 1971 Apr; 47(8):235-6. PubMed ID: 4328581
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.